Clinical Trial

BETA - Pilot Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and Oura ring and the Empatica EmbracePlus smart wristband to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being initially done with individuals with Type 1 diabetes, so that in the future these methods can be tested in a larger study of individuals with Type 2 diabetes or prediabetics. The eventual aim of this work is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes and Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.
Trial Details
NCT Number NCT07192861
Lead Sponsor 4YouandMe
Collaborators: Buck Institute for Research on Aging, Phenome Health
Conditions Diabetes (DM)
Enrollment 28 participants
Start Date 2025-07-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-25